Product
Liposomal Cyclosporine A
Aliases
L-CsA
4 clinical trials
11 indications
Indication
Lung Transplant ComplicationsIndication
Lung Transplant Failure and RejectionIndication
Chronic Lung Allograft DysfunctionIndication
Bronchiolitis ObliteransIndication
Chronic Lung Transplant RejectionIndication
Lung Transplant RejectionIndication
Bronchiolitis Obliterans SyndromeIndication
Graft-versus-host diseaseIndication
ChronicIndication
Stem Cell Transplant ComplicationsIndication
Constrictive BronchiolitisClinical trial
A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung TransplantStatus: Active (not recruiting), Estimated PCD: 2024-04-05
Clinical trial
A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung TransplantStatus: Active (not recruiting), Estimated PCD: 2024-04-05
Clinical trial
A Phase IIa Multi-Center, Randomized, Single-Blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell TransplantationStatus: Terminated, Estimated PCD: 2022-06-16